Gamma Biosciences acquires Nanopareil

By The Science Advisory Board staff writers

October 1, 2020 -- Gamma Biosciences has purchased nanofiber membrane product developer Nanopareil.

Nanopareil's products are used for chromatographic separation in bioproduction and consist of a nanofiber structure that performs better than conventional chromatography resins, Gamma Biosciences said.

The company plans to manage Nanopareil as part of its Astrea Bioseparations subsidiary. The purchase will boost Astrea's ability to develop custom separation products for a range of biopharmaceutical applications, Gamma Biosciences said.

Sciex, 908 Devices launch biotherapeutics characterization platform
Sciex and 908 Devices have made the ZipChip platform for Sciex mass spectrometers available to the public. This platform expands mass spectrometers from...
Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp...

Copyright © 2020

Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter